tiprankstipranks
Global Blood Therapeutics (GBT)
NASDAQ:GBT

Global Blood Therapeutics (GBT) Stock Investors

0 Followers
Based on 604,997 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GBT
On average, investors allocate 3.87% of their portfolios to GBT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 604,997 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GBT

0.4%
Last 7
Days
2.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GBT, out of 604,997 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GBT Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
2.78%
$63.84
Based on the activity of 11,500 investors who made their portfolios public
The table shows changes in GBT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GBT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Gilead Sciences
4.02%
-0.64%
-0.90%
82.03B
Healthcare
JD
4.15%
-0.48%
-1.40%
83.69B
Consumer Goods
Baidu
4.78%
-0.42%
-1.17%
44.35B
Technology
Novavax
4.28%
-0.37%
-1.90%
1.46B
Healthcare
Crispr Therapeutics AG
4.10%
-0.58%
-1.81%
5.04B
Healthcare
Bristol Myers
3.99%
-0.30%
-0.02%
152.56B
Healthcare
ServiceNow
3.45%
-0.05%
-1.19%
84.96B
Technology
Diamondback
5.27%
+0.50%
+1.84%
24.79B
Utilities
Workhorse Group
3.33%
-0.67%
-2.03%
455.20M
Consumer Goods
Canopy Growth
3.86%
+0.30%
+1.45%
1.48B
Basic Materials
Based on the activity of 604,997 active portfolios
Open your Smart Portfolio

GBT Investor Analysis

GBT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
0.0%
of GBT holders
are under 35
Average Segment Performance
Average P/E Ratio13.47
Beta5.22
Dividend Yield5.35%
GBT investors between 35–55

Between 35–55

3.0%
Last 30 days
Holdings Change
100.0%
of GBT holders
are between 35–55
Average Segment Performance
Average P/E Ratio11.67
Beta1.04
Dividend Yield5.37%
GBT investors over 55

Over 55

2.9%
Last 30 days
Holdings Change
0.0%
of GBT holders
are over 55
Average Segment Performance
Average P/E Ratio11.87
Beta0.90
Dividend Yield4.58%
Overview of age group and performance of GBT stock investors
See who invests in GBT according to age group and performance.

FAQ

How many retail Investors hold GBT?
<0.1% of TipRanks' retail investors hold GBT in their portfolios.
    What is GBT Investor Sentiment?
    GBT’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GBT in the last 7 days?
      ▼ 0.4% of TipRanks' retail investors changed their holding of GBT in the last 7 days.
        What percentage of retail investors changed their holding of GBT in the last 30 days?
        ▼ 2.7% of TipRanks' retail investors changed their holding of GBT in the last 30 days.
          What is the average age of retail investors who hold GBT?
          The average age of GBT Holders is between 35–55.
            What other stocks have GBT investors also bought?
            GBT Investors also bought GILD, JD, BIDU, NVAX, CRSP, BMY, NOW, FANG, WKHS, CGC.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AAgilent
              ALNYAlnylam Pharma
              AVEOAVEO Pharma
              BLRXBioline RX Ltd Sponsored ADR
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis